What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?. [Review]
Citation: Lancet. 399(10325):691-694, 2022 02 12.PMID: 35033221Institution: MedStar Health Research InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Angina Pectoris/th [Therapy] | *Angina, Stable/th [Therapy] | *Clinical Trials as Topic | *Disease Management | Cardiovascular Agents/tu [Therapeutic Use] | Computed Tomography Angiography | Echocardiography | Humans | Myocardial Revascularization | Percutaneous Coronary Intervention | Referral and ConsultationYear: 2022Local holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library: 1983 - 2007Originally published: Lancet. 399(10325):691-694, 2022 Feb 12.Fiscal year: FY2022Digital Object Identifier: Date added to catalog: 2022-02-21| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Journal Article | MedStar Authors Catalog | Article | 35033221 | Available | 35033221 |
Available online from MWHC library: 1995 - present, Available in print through MWHC library: 1983 - 2007
English